Synthesis of novel, DNA binding heterocyclic dehydroabietylamine derivatives as potential antiproliferative and apoptosis-inducing agents.

Clicks: 427
ID: 91072
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #4 of 54 articles by views in drug delivery

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Several dehydroabietylamine derivatives containing heterocyclic moieties such as thiophene and pyrazine ring were successfully synthesized. The antiproliferative activities of these thiophene-based Schiff-bases, thiophene amides, and pyrazine amides were investigated against Hela (cervix), MCF-7 (breast), A549 (lung), HepG2 (liver), and HUVEC (umbilical vein) cells by MTT assay. The toxicity of - (IC = 5.92- >100 μM) was lower than (1.27 μM) and DOX (4.40 μM) in every case. Compound had higher anti-HepG2 0.66 μM), anti-MCF-7 (5.33 μM), and anti-A549 (2.11 μM) and compound had higher anti-HepG2 (1.63 μM) and anti-MCF-7 (2.65 μM) activities. Both of these compounds were recognized with high efficiency in apoptosis induction in HepG2 cells and intercalated binding modes with DNA. Moreover, with average IC values of 0.66 and 5.98 μM, was nine times more effective at suppressing cultured HepG2 cells viability than normal cells (SI = 9). The relative tumor proliferation rate (T/C) was 38.6%, the tumor inhibition rate was up to 61.2%, which indicated that had no significant toxicity but high anti-HepG2 activity . Thus, it may be a potential antiproliferation drug with nontoxic side effects.
Reference Key
zhao2020synthesisdrug Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Zhao, Fengyi;Sun, Xu;Lu, Wen;Xu, Li;Shi, Jiuzhou;Yang, Shilong;Zhou, Mengyi;Su, Fan;Lin, Feng;Cao, Fuliang;
Journal drug delivery
Year 2020
DOI
10.1080/10717544.2020.1716879
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.